Cancer patient in remission after 'amazing' outcome of targeted trial (opens original article in a new tab)

A cancer patient in Australia achieved remission after participating in a targeted clinical trial, with doctors using genetic sequencing to customize his treatment and starve the cancer by blocking its protein growth.

• Ben Whitehead entered remission for stage four peripheral T-cell lymphoma after a clinical trial
• Doctors used genetic sequencing to tailor treatment for his specific cancer
• Whitehead's treatment involved targeted therapy that starved the cancer by blocking its protein growth